<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="ProgId" content="Word.Document"><meta name="Generator" content="Microsoft Word 11"><meta name="Originator" content="Microsoft Word 11"><link rel="File-List" href="file:///C:%5CUsers%5CHani%5CAppData%5CLocal%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"><style>
<!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;
mso-font-charset:2;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
{font-family:SimSun;
panose-1:2 1 6 0 3 1 1 1 1 1;
mso-font-alt:宋体;
mso-font-charset:134;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-1610611985 1073750139 0 0 159 0;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-1593833729 1073750107 16 0 415 0;}
@font-face
{font-family:"\@SimSun";
panose-1:2 1 6 0 3 1 1 1 1 1;
mso-font-charset:134;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 680460288 22 0 262145 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0in;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:SimSun;
color:windowtext;
mso-fareast-language:ZH-CN;}
h2
{mso-style-next:Normal;
margin-top:12.0pt;
margin-right:0in;
margin-bottom:3.0pt;
margin-left:0in;
mso-pagination:widow-orphan;
page-break-after:avoid;
mso-outline-level:2;
font-size:14.0pt;
font-family:Arial;
mso-fareast-font-family:SimSun;
color:windowtext;
mso-fareast-language:ZH-CN;
font-weight:bold;
font-style:italic;}
h3
{mso-style-link:" Char Char";
margin-top:12.0pt;
margin-right:0in;
margin-bottom:12.0pt;
margin-left:0in;
mso-pagination:widow-orphan;
mso-outline-level:3;
font-size:8.5pt;
font-family:"Times New Roman";
mso-fareast-font-family:SimSun;
color:windowtext;
mso-fareast-language:ZH-CN;
font-weight:bold;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
{margin-top:0in;
margin-right:0in;
margin-bottom:6.0pt;
margin-left:0in;
mso-pagination:widow-orphan;
font-size:8.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";
color:windowtext;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;
text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
{color:purple;
text-decoration:underline;
text-underline:single;}
em
{font-weight:bold;
font-style:normal;}
p
{mso-style-name:"Normal \(Web\)\, webb";
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
mso-pagination:widow-orphan;
font-size:8.5pt;
font-family:Verdana;
mso-fareast-font-family:SimSun;
mso-bidi-font-family:"Times New Roman";
color:black;
mso-fareast-language:ZH-CN;}
span.CharChar
{mso-style-name:" Char Char";
mso-style-locked:yes;
mso-style-link:"Heading 3";
mso-ansi-font-size:8.5pt;
mso-bidi-font-size:8.5pt;
font-family:SimSun;
mso-fareast-font-family:SimSun;
mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;
mso-bidi-language:AR-SA;
font-weight:bold;}
p.ListParagraph, li.ListParagraph, div.ListParagraph
{mso-style-name:"List Paragraph";
margin-top:0in;
margin-right:0in;
margin-bottom:10.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:Calibri;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";
color:windowtext;
mso-fareast-language:EN-US;}
p.ListParagraphCxSpFirst, li.ListParagraphCxSpFirst, div.ListParagraphCxSpFirst
{mso-style-name:"List ParagraphCxSpFirst";
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:Calibri;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";
color:windowtext;
mso-fareast-language:EN-US;}
p.ListParagraphCxSpMiddle, li.ListParagraphCxSpMiddle, div.ListParagraphCxSpMiddle
{mso-style-name:"List ParagraphCxSpMiddle";
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:Calibri;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";
color:windowtext;
mso-fareast-language:EN-US;}
p.ListParagraphCxSpLast, li.ListParagraphCxSpLast, div.ListParagraphCxSpLast
{mso-style-name:"List ParagraphCxSpLast";
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:10.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:Calibri;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";
color:windowtext;
mso-fareast-language:EN-US;}
@page Section1
{size:8.5in 11.0in;
margin:1.0in 1.25in 1.0in 1.25in;
mso-header-margin:.5in;
mso-footer-margin:.5in;
mso-paper-source:0;}
div.Section1
{page:Section1;}
/* List Definitions */
@list l0
{mso-list-id:167719602;
mso-list-type:hybrid;
mso-list-template-ids:-1800269106 285645534 1686166816 69009413 69009409 69009411 69009413 69009409 69009411 69009413;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.25in;
mso-level-number-position:left;
margin-left:17.0pt;
text-indent:-17.0pt;
mso-ansi-font-size:11.0pt;
font-family:Symbol;
letter-spacing:-1.0pt;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:73.85pt;
mso-level-number-position:left;
margin-left:71.0pt;
text-indent:-17.0pt;
mso-ansi-font-size:11.0pt;
font-family:Symbol;
letter-spacing:-1.0pt;}
@list l1
{mso-list-id:455609604;
mso-list-type:hybrid;
mso-list-template-ids:-1422858070 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2
{mso-list-id:894894318;
mso-list-type:hybrid;
mso-list-template-ids:-1847058700 134807553 134807555 134807557 134807553 134807555 134807557 134807553 134807555 134807557;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:.75in;
text-indent:-.25in;
font-family:Symbol;}
@list l3
{mso-list-id:923220803;
mso-list-type:hybrid;
mso-list-template-ids:1182172878 814000566 69009411 69009413 69009409 69009411 69009413 69009409 69009411 69009413;}
@list l3:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:14.2pt;
mso-level-number-position:left;
margin-left:11.35pt;
text-indent:-11.35pt;
font-family:Symbol;}
@list l4
{mso-list-id:974800688;
mso-list-type:hybrid;
mso-list-template-ids:1310364626 134807567 134807553 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
{mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l4:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l5
{mso-list-id:1297954677;
mso-list-type:hybrid;
mso-list-template-ids:-1457999150 269221889 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l5:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.25in;
mso-level-number-position:left;
margin-left:.25in;
text-indent:-.25in;
font-family:Symbol;}
@list l6
{mso-list-id:1343239694;
mso-list-template-ids:-850334110;}
@list l6:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:-.25in;
mso-level-number-position:left;
margin-left:-.25in;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l6:level2
{mso-level-tab-stop:.25in;
mso-level-number-position:left;
margin-left:.25in;
text-indent:-.25in;}
@list l6:level3
{mso-level-tab-stop:.75in;
mso-level-number-position:left;
margin-left:.75in;
text-indent:-.25in;}
@list l6:level4
{mso-level-tab-stop:1.25in;
mso-level-number-position:left;
margin-left:1.25in;
text-indent:-.25in;}
@list l6:level5
{mso-level-tab-stop:1.75in;
mso-level-number-position:left;
margin-left:1.75in;
text-indent:-.25in;}
@list l6:level6
{mso-level-tab-stop:2.25in;
mso-level-number-position:left;
margin-left:2.25in;
text-indent:-.25in;}
@list l6:level7
{mso-level-tab-stop:2.75in;
mso-level-number-position:left;
margin-left:2.75in;
text-indent:-.25in;}
@list l6:level8
{mso-level-tab-stop:3.25in;
mso-level-number-position:left;
margin-left:3.25in;
text-indent:-.25in;}
@list l6:level9
{mso-level-tab-stop:3.75in;
mso-level-number-position:left;
margin-left:3.75in;
text-indent:-.25in;}
@list l7
{mso-list-id:1349482508;
mso-list-type:hybrid;
mso-list-template-ids:234529398 269221889 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l7:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l8
{mso-list-id:1412778096;
mso-list-type:hybrid;
mso-list-template-ids:-1808606060 134807567 134807577 134807579 134807567 134807577 134807579 134807567 134807577 134807579;}
@list l8:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l9
{mso-list-id:1493763748;
mso-list-type:hybrid;
mso-list-template-ids:-485689860 814000566 1686166816 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l9:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:14.2pt;
mso-level-number-position:left;
margin-left:11.35pt;
text-indent:-11.35pt;
font-family:Symbol;}
@list l9:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:73.85pt;
mso-level-number-position:left;
margin-left:71.0pt;
text-indent:-17.0pt;
font-family:Symbol;}
@list l10
{mso-list-id:1834490522;
mso-list-type:hybrid;
mso-list-template-ids:2086722558 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l10:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
-->
</style>
<p class="MsoNormal" style="margin-bottom: 6pt;"><b><span style="font-size: 10pt; font-family: Arial;">Posted by the PHM Global Secretariat<br></span></b></p><p class="MsoNormal" style="margin-bottom: 6pt;"><span style="font-size: 10pt; font-family: Arial;"><br>
</span></p><p class="MsoNormal" style="margin-bottom: 6pt;"><span style="font-size: 10pt; font-family: Arial;">The <u><span style="color: rgb(0, 112, 192);"><a href="http://www.who.int/eth/en/"><span style="color: rgb(0, 112, 192);">WHO Scientific
Resource Group on Equity Analysis and Research</span></a></span></u> together
with the <u><span style="color: rgb(0, 112, 192);"><a href="http://www.globalforumhealth.org/"><span style="color: rgb(0, 112, 192);">Global Forum
for Health Research</span></a></span></u> and <u><span style="color: rgb(0, 112, 192);"><a href="http://www.phmovement.org/"><span style="color: rgb(0, 112, 192);">People's Health
Movement</span></a></span></u></span><i><span style="font-size: 10pt; font-family: Arial;"> </span></i><span style="font-size: 10pt; font-family: Arial;">announce
a call for research proposals from civil society organizations (CSOs) on the
theme:</span></p>
<p class="MsoNormal" style="margin-bottom: 6pt;"><span style="font-size: 10pt; font-family: Arial;">‘Advancing health equity through research and practice – identifying
what works to reduce health inequities</span><span style="font-size: 10pt; font-family: Arial;">’.</span></p>
<p class="MsoNormal" style="margin-bottom: 12pt;"><b><span style="font-size: 10pt; font-family: Arial; color: rgb(0, 32, 96);">Deadline for receipt
of entries is 23 May 2010</span></b><span style="font-size: 10pt; font-family: Arial; color: rgb(0, 32, 96);"></span></p>
<p><span style="font-size: 10pt; font-family: Arial; color: windowtext;">CSOs
interested in evaluating the interventions they implemented and </span><span style="font-size: 10pt; font-family: Arial; color: windowtext;" lang="EN-GB">their impacts both on health
outcomes and on health equity</span><span style="font-size: 10pt; font-family: Arial; color: windowtext;" lang="EN-GB"> </span><span style="font-size: 10pt; font-family: Arial; color: windowtext;">are invited to submit research proposals. The
interventions </span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">(including policies,
programmes, etc) </span><span style="font-size: 10pt; font-family: Arial; color: windowtext;">to be evaluated need to address </span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">social, economic and political determinants of health.</span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB"> </span><span style="font-size: 10pt; font-family: Arial;">Submission of proposals dealing with
interventions and research projects already in progress is strongly encouraged.</span><span style="font-size: 10pt; font-family: Arial; color: windowtext;"></span></p>
<h2 style="margin-top: 24pt;"><span style="" lang="EN-GB">Background</span></h2>
<p class="MsoNormal" style=""><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">Published research</span><span style="font-size: 10pt; font-family: Arial;"> oriented toward reducing health inequity
has until recently been devoted more to explaining health inequities than to
designing and evaluating policy interventions to reduce inequities.</span><span style="font-size: 10pt; font-family: Arial;"> </span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">Research is needed to evaluate the health equity impact of policy and actions, whether in the
health sector or in other sectors. One of the three top level recommendations
by the WHO Commission on Social Determinants of Health (CSDH) is to continue
research, monitoring and evaluation, with a focus on what interventions work to
reduce health inequities. The recent <a href="http://www.globalhealthequity.ca/electronic%20library/Priorities%20for%20research%20on%20equity%20and%20health.pdf">WHO
Task Force Report on “Priorities for research on equity and health”</a>, called
for a third wave in global health research, that explicitly links broader
social, political, and economic determinants with improvements in equity in health, and emphasized the need for
innovative research designs for evaluating policy and program interventions to
reduce health inequities.</span></p>
<p class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">Local
level solutions and those addressing a broad range of social determinants are
often those with the greatest innovation and impact. For example, policies and projects
addressing issues such as provision of education, water and sanitation, and farming
technologies or the empowerment of disadvantaged groups have significant
potential consequences for health and health equity.
Civil Society Organizations (CSOs) often lead the development and
implementation of such interventions that lead to concrete improvements in real
life settings, and yet CSOs don't always have the opportunity to document or
evaluate interventions that are in place. Moreover, CSOs</span><span style="font-size: 10pt; font-family: Arial;"> need to be viewed as potential
partners in the entire research process, i.e. from the design stage to
dissemination cycle, and should not be viewed as merely being capable of
voicing “community needs” or disseminating research findings.</span><span style="font-size: 10pt; font-family: Arial;"> <span lang="EN-GB">In addition, </span></span><span style="font-size: 10pt; font-family: Arial;">research funding needs to be sensitive to the necessity for civil
society participation throughout - from the stage of priority setting to
refining evaluation methods and to communicating what concrete actions can be taken
to reduce health inequities. Finally, civil society has a key role in policy
change through its constituencies in engaging on and influencing policy
choices, and in linking the evidence and knowledge from research to policy
processes. These processes were discussed and further reinforced during the Global
Ministerial Forum on Research for Health 2008 in Bamako
and during Global Forum on Health Research 2009 in Havana.</span></p>
<div style="border: 1pt solid windowtext; padding: 1pt 4pt;">
<p class="MsoNormal" style="margin-top: 6pt; border: medium none; padding: 0in;"><b style=""><i style=""><span style="font-size: 11pt; font-family: Calibri;"><span style=""> </span></span></i></b><b style=""><span style="font-size: 11pt; font-family: Calibri;">Examples of high-priority research questions
addressing action on social determinants of health</span></b></p>
<p class="MsoNormal" style="border: medium none; padding: 0in;"><b style=""><i style=""><span style="font-size: 11pt; font-family: Calibri;"> </span></i></b></p>
<p style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 11pt; font-family: Symbol; letter-spacing: -1pt;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that address<span style="">
</span>health equity implications of
current trends in food prices, agricultural policies and food (in)security, and
changes in trade and investment in all aspects of food production, processing
and sale.<span style=""> </span>What policy and program
responses will avoid negative impacts, and reduce food insecurity? </span></span><span style="font-size: 10pt; font-family: Calibri;" lang="EN-GB"></span></p>
<p style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 11pt; font-family: Symbol; letter-spacing: -1pt;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that address different </span></span><span style="font-size: 10pt; font-family: Calibri;" lang="EN-GB">policy
entry points to reduce the health inequities arising from health worker
migration patterns, identifying the critical policy actors. </span></p>
<p class="MsoNormal" style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 11pt; font-family: Symbol; letter-spacing: -1pt;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that address women’s health and social
protection given the increasing “feminisation” of work forces that has often
accompanied the globalisation of labour markets. </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that address health equity
with global climate change concerns, at the local level. </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that use organisational structures within health
systems to sustain active community participation, inter-sectoral action on
social determinants of health, and the abilities of community members to
influence policies. </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; page-break-after: avoid; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Symbol;" lang="EN-CA"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;">Interventions that combine policy and implementation
models, across sectors, that lead to improved local decision-making, net health
equity gains in different vulnerable
populations and community empowerment? </span></span><span style="font-size: 10pt; font-family: Calibri;" lang="EN-CA"></span></p>
<p class="MsoNormal" style="margin: 0in 0in 6pt 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Symbol;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;" lang="EN-GB">Interventions and
approaches that effectively involve </span></span><span style="font-size: 10pt; font-family: Calibri;">targeted communities or populations in intervention
development, implementation and evaluation?</span><span style="font-size: 10pt; font-family: Calibri;" lang="EN-GB"> </span></p>
<p class="MsoBodyText3" style="margin-left: 17pt; text-indent: -17pt; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Calibri;" lang="EN-GB">Interventions that
effectively </span></span><span style="font-size: 10pt; font-family: Calibri;">involve
other sectors than the health sector in action oriented approaches to address
health inequalities related to a wide range of health hazards (environmental,
occupational, infrastructure such as roads, sanitation, etc.)?</span></p>
</div>
<h2 style="margin-top: 24pt;">Purpose of the call</h2>
<p style="margin-bottom: 0.0001pt;"><span style="font-size: 10pt; font-family: Arial;">This call for research proposals aims at:</span></p>
<p style="margin: 6pt 0in 5pt 17.85pt; text-indent: -17.85pt;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Identifying the four most promising operational research and
evaluation proposals submitted by CSOs;</span></span></p>
<p style="margin: 6pt 0in 5pt 17.85pt; text-indent: -17.85pt;"><span style="font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">Refining methods, particularly
on the attribution of changes in the distribution of health resulting from the
interventions, and considerations to increase the interpretation and potential generalisability
of results. For this, selected research proposals will be presented, discussed
and improved during the 20<sup>th</sup> IUHPE World Conference on Health
Promotion, in Geneva, Switzerland;</span></span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB"> </span></p>
<p style="margin: 6pt 0in 5pt 17.85pt; text-indent: -17.85pt;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Facilitating the conduct of winning research proposals by expert
mentoring, facilitating contacts with potential research funders, a cash award of
up to USD 10,000 (to contribute to evaluation of the intervention) and
facilitating the dissemination of results.</span></span></p>
<h2 style="margin-top: 24pt;">Eligibility to apply for the call</h2>
<p style="margin-left: 0.25in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">The Principal Investigator in the proposal must be drawn
from a civil society organization (CSO), such as registered charities,
development NGOs, community groups, women's organizations, faith-based
organizations, professional associations, trade unions, self-help groups,
social movements, business associations, coalitions and advocacy groups.</span></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Research proposals </span></span><span style="font-size: 10pt; font-family: Arial;" lang="EN-GB">must be aimed at <u>evaluating interventions
(including policies, programmes, etc) addressing social, economic and political
determinants of health, and their impacts both on health outcomes and on health
equity</u>. The evaluation should
examine inequities among different social groups, not only between one disadvantaged
group and a population average. Interventions are those implemented by civil
society organizations (CSOs) and could potentially be adapted for
implementation in other countries.</span><span style="font-size: 10pt; font-family: Arial;"></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Teams submitting expressions of interest should demonstrate
expertise in research for health or development, <span style="">ability to design evaluation studies and</span> ability to analyze data
to evaluate impacts of interventions on health and health equity. Demonstration
of advanced writing skills will be an advantage.</span></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Submission of proposals dealing with interventions and research
projects already in progress is strongly encouraged.</span></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">A budget and timeline must be included, specifying how the case
award will contribute to the overall evaluation of the intervention.</span></span></p>
<h2 style="margin-top: 24pt;">Selection Criteria</h2>
<p class="MsoNormal" style=""><span style="font-size: 10pt; font-family: Arial;">Proposals will be evaluated according to the following
criteria:</span></p>
<ol style="margin-top: 0in;" start="1" type="1"><li class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">Relevance
of the intervention to be evaluated and its potential impact on public
health and equity (25%)</span></li></ol>
<p class="MsoNormal" style="margin: 6pt 0in 0.0001pt 0.75in; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Does the research evaluation involve the participation of
individuals that should benefit from the intervention?<span style=""> </span>Does the intervention address broader
determinants of health?</span></span></p>
<ol style="margin-top: 0in;" start="2" type="1"><li class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">Appropriateness
of the methodological approach proposed for evaluating and documenting the
success of the intervention on health equity,
and exploring the factors responsible for success (25%)</span></li></ol>
<p class="ListParagraphCxSpFirst" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Can the question proposed be answered through well-designed
and conducted evaluation?</span></span></p>
<p class="ListParagraphCxSpMiddle" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Does the applicant
acknowledge potential problem areas and consider alternative tactics?</span></span><span style="font-size: 10pt; font-family: Arial;"></span></p>
<p class="ListParagraphCxSpLast" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Does the project develop or
employ novel concepts, approaches, methodologies, tools, or technologies for
this area of investigation? </span></span><span style="font-size: 10pt; font-family: Arial;"></span></p>
<ol style="margin-top: 0in;" start="3" type="1"><li class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">Technical
capacity of the proposed research team and appropriateness of budget and
timeline proposed (25%)</span></li></ol>
<p class="ListParagraphCxSpFirst" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Is the research that is
proposed logistically feasible, financially possible, and likely to produce
timely results?<span style=""> </span></span></span><span style="font-size: 10pt; font-family: Arial;"></span></p>
<p class="ListParagraphCxSpMiddle" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Does the investigative team
bring complementary and integrated expertise to the project?</span></span><span style="font-size: 10pt; font-family: Arial;"></span></p>
<p class="ListParagraphCxSpLast" style="margin: 0in 0in 0.0001pt 0.75in; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol; color: black; letter-spacing: 0.15pt;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Does the proposed study
benefit from unique features of the population the intervention addresses
and/or employ useful collaborative arrangements? </span></span></p>
<ol style="margin-top: 0in;" start="4" type="1"><li class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">Scope
for learning lessons, generalisability of results and potential
application to other contexts (25%)</span></li></ol>
<p class="MsoNormal" style="margin: 6pt 0in 0.0001pt 56.7pt; text-indent: -0.25in;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">What scope will the findings have to influence public policy
and stimulate further action?</span></span></p>
<p class="ListParagraphCxSpFirst" style="margin: 0in 0in 0.0001pt 56.7pt; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">How feasible will it be to rapidly and widely implement the
results of the research study?</span></span></p>
<p class="ListParagraphCxSpLast" style="margin: 0in 0in 0.0001pt 56.7pt; text-indent: -0.25in; line-height: normal;"><span style="font-size: 10pt; font-family: Symbol;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black; letter-spacing: 0.15pt;">Will</span></span><span style="font-size: 10pt; font-family: Arial;"> the answers to the research
question be generalizable to different settings, in the country and potentially
beyond?</span></p>
<p class="MsoNormal" style="margin: 6pt 0in 0.0001pt 0.75in;"><span style="font-size: 10pt; font-family: Arial;"> </span></p>
<p class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">The final selection of proposals will be made principally
upon the scores awarded to the proposals, but will also take account of
geographical distribution of submissions and country income classification.</span></p>
<p class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;">The sponsoring organizations reserve the right to select
fewer applicants.</span></p>
<p class="MsoNormal" style="margin-top: 6pt;"><span style="font-size: 10pt; font-family: Arial;"> </span></p>
<div style="border: 1pt solid windowtext; padding: 1pt 4pt;">
<h2 style="border: medium none; padding: 0in;">Format of Application </h2>
<p class="MsoNormal" style="border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;">The application should not be longer than four pages
or 2000 words, with the following <em><span style="font-weight: normal;">outline</span></em>: </span></p>
<p class="MsoNormal" style="margin-left: 0in; text-indent: 0in; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;"><span style="">1.<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Intervention to be evaluated</span></span></p>
<p class="MsoNormal" style="margin-left: 28.35pt; text-indent: -28.35pt; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;"><span style="">2.<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Methodology, including how equity impact (distribution of
health) on the population will be assessed and what dimensions of equity will
be looked at.</span></span></p>
<p class="MsoNormal" style="margin-left: 0in; text-indent: 0in; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;"><span style="">3.<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">How the results of the evaluation will be potentially useful
to other contexts</span></span></p>
<p class="MsoNormal" style="margin-left: 0in; text-indent: 0in; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;"><span style="">4.<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Team</span></span></p>
<p class="MsoNormal" style="margin-left: 0in; text-indent: 0in; border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;"><span style="">5.<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial;">Budget and timeline</span></span></p>
<p class="MsoNormal" style="border: medium none; padding: 0in;"><span style="font-size: 10pt; font-family: Arial;">The application should be completed in any of the UN
official languages (Arabic, Chinese, English, French, Russian, Spanish). If you
want to submit in another language, please request in advance.</span></p>
</div>
<h2 style="margin-top: 24pt;">Selection process</h2>
<p style="margin: 6pt 0in 0.0001pt;"><span style="font-size: 10pt; font-family: Arial;">Step 1:
The WHO Scientific Resource Group (SRG) on Equity Analysis and Research, sub-group
on research and the Global Forum for Health Research will screen all
applications according to the eligibility criteria. The ones which are
incomplete will, in principle, not be processed further.</span></p>
<p style="margin: 6pt 0in 0.0001pt;"><span style="font-size: 10pt; font-family: Arial;">Step 2:
Applications (without identification data) will be sent to and evaluated by the
selection committee, composed of experts in the field of Equity Analysis and
Research, including individuals from the SRG on Health Equity Analysis and
Research and People’s Health Movement.</span></p>
<p style="margin: 6pt 0in 0.0001pt;"><span style="font-size: 10pt; font-family: Arial;">Step 3:
Applicants will be notified in June 2010 as to whether or not they have been
selected. Up to four winning proposals will be </span><strong><span style="font-size: 10pt; font-family: Arial; font-weight: normal;" lang="EN-GB">posted on the PHM-GFHR-WHO websites for open consultation and principal
investigators be invited (travel, registration and accommodation paid) to
present their proposals during the IUHPE Conference in Geneva</span></strong><span style="font-size: 10pt; font-family: Arial;">.</span></p>
<p style="margin: 6pt 0in 0.0001pt;"><span style="font-size: 10pt; font-family: Arial;">Step 4:
Proposals will be amended by the research teams and the winners granted with a
first installment of half of the award, a quarter after interim progress report
and a quarter after final report.</span></p>
<h2 style="margin-top: 24pt;">Key dates</h2>
<p class="MsoNormal" style="margin: 12pt 0in 0.0001pt 106.35pt; text-indent: -106.35pt;"><strong><span style="font-size: 10pt; font-family: Symbol; color: black; font-weight: normal;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span></strong><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">21 April 2010<span style=""> </span>Opening
date for applications </span></strong></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><strong><span style="font-size: 10pt; font-family: Symbol; color: black; font-weight: normal;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span></strong><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">23 May 2010<span style=""> </span>Deadline
for submission of applications </span></strong></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;"><span style="">·<span style="font: 7pt "Times New Roman";"> </span></span></span><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">30 May to 4 June<span style=""> </span>Selection of applications</span></strong></span><b><span style="font-size: 10pt; color: black;"></span></b></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">7 June 2010<span style=""> </span>Successful
applicants informed</span></strong></span><b><span style="font-size: 10pt; color: black;" lang="EN-GB"> </span></b><b><span style="font-size: 10pt; color: black;" lang="EN-GB"></span></b></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">14 June 2010<span style=""> </span>Proposals
posted on PHM-Global Forum-WHO websites for open consultation</span></strong></span><b><span style="font-size: 10pt; color: black;" lang="EN-GB"> </span></b><b><span style="font-size: 10pt; color: black;" lang="EN-GB"></span></b></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;" lang="EN-GB"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">11-15 July 2010<span style=""> </span>Session
during IUHPE World Conference on Health Promotion in Geneva: successful applicants present more
details on their proposals and an expert panel and audience</span></strong></span><span style="font-size: 10pt; font-family: Arial; color: black;" lang="EN-GB"> </span><span style="font-size: 10pt; font-family: Arial; color: black;">further discusses</span><span style="font-size: 10pt; font-family: Arial; color: black;" lang="EN-GB"></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><strong><span style="font-size: 10pt; font-family: Symbol; color: black; font-weight: normal;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span></strong><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">1 September 2010<span style=""> </span>Final
proposals posted on PHM-Global Forum-WHO websites.</span></strong></span><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;"></span></strong></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;" lang="EN-GB">September 2010<span style=""> </span>Initiation
of intervention evaluation research</span></strong></span><b><span style="font-size: 10pt; color: black;" lang="EN-GB"> </span></b><span style="font-size: 10pt; font-family: Arial; color: black;"></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black;">July 2011<span style=""> </span>Interim progress report</span></span><span style="font-size: 10pt; font-family: Arial; color: black;"></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black;">March 2012<span style=""> </span>Final
report</span></span></p>
<p class="MsoNormal" style="margin-left: 106.35pt; text-indent: -106.35pt;"><span style="font-size: 10pt; font-family: Symbol; color: black;"><span style="">·<span style="font: 7pt "Times New Roman";">
</span></span></span><span dir="LTR"><span style="font-size: 10pt; font-family: Arial; color: black;">June 2012<span style=""> </span>Learning
across all projects synthesized</span></span></p>
<p class="MsoNormal" style=""><strong><span style="font-size: 10pt; font-family: Arial; color: black; font-weight: normal;"> </span></strong></p>
<h3><span style="font-size: 10pt; font-family: Arial; color: navy;">The application
should be emailed as a Word or PDF document to <a href="mailto:sylvie.olifson@globalforumhealth.org">sylvie.olifson@globalforumhealth.org</a>.
In the header of the email, please put "CSOs advancing health equity”. Receipt
of applications will be confirmed by e-mail. <br>
</span><span style="font-size: 10pt; font-family: Arial; color: maroon;">The
deadline for submission is 23 May 2010.</span><span style="font-size: 10pt; font-family: Arial; color: navy;"></span></h3>
<br clear="all">--<br>Global Secretariat<br>People's Health Movement (PHM)<br>Email: <a href="mailto:globalsecretariat@phmovement.org">globalsecretariat@phmovement.org</a><br>Web: <a href="http://www.phmovement.org">www.phmovement.org</a><br>
<input id="gwProxy" type="hidden"><input onclick="jsCall();" id="jsProxy" type="hidden"><div id="refHTML"></div>